End-point selection to determine the airway-systemic ratio of inhaled corticosteroids in asthma
- PMID: 33230858
- DOI: 10.1111/bcp.14633
End-point selection to determine the airway-systemic ratio of inhaled corticosteroids in asthma
Abstract
The use of adenosine monophosphate challenge and basal cortisol as short-term surrogate end points of airway-systemic effects of inhaled corticosteroids in asthma is not suitable to properly determine the clinically relevant long-term therapeutic index.
© 2020 British Pharmacological Society.
Comment on
-
Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppression.Br J Clin Pharmacol. 2021 Feb;87(2):483-493. doi: 10.1111/bcp.14406. Epub 2020 Jun 17. Br J Clin Pharmacol. 2021. PMID: 32484940 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical